We're so glad you're here! This site is to help anyone diagnosed with Medullary Thyroid Cancer and their caregivers find valuable information and support. If you'd like to connect with others with MTC, please consider joining our very active Facebook Group. You don't have to go through this alone!
If you don't yet have a copy, please download the American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma, aka "The Guidelines." This is the MTC Bible. Read it and know it and it will help you and your doctor ensure you get the proper treatment.
Lastly, please consider looking into being seen by an MTC expert. We do our best to keep a running list of what we call "Centers of Excellence." These are doctors and facilities that are properly trained and experienced enough to treat MTC patients. It's one of the most important decisions you can make on your journey.
"... selpercatinib for pediatric RET-altered metastatic thyroid cancer or solid tumors. FDA granted accelerated approval to selpercatinib (Retevmo, Eli ..."
"These cancers are called familial medullary thyroid carcinoma. They can start in childhood or early adulthood and spread early. Some people who have ..."
"The Medullary Thyroid Cancer Treatment Market, assessed at $412.5 Million in 2026, is projected to expand to $745.7 Million by 2035, registering a ..."
"Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib: Results from the RET- ..."
"Less than 5% of cancer cases are medullary, with a quarter linked to an inherited condition called multiple endocrine neoplasia type 2. See Also."
This website is intended for educational purposes only. It is not intended, nor should it be interpreted, as medical advice or instructions of any kind. Readers are advised to consult their own medical doctor(s) for all matters involving their health and medical care.